CNBC Daily Open: U.S. to Raise Tariffs on Generic Drugs, AI Developments, and Earnings Reports Ahead
Investors face significant developments today, including a proposed increase in tariffs on generic drugs by the U.S. government, which could impact the pharmaceutical sector, particularly companies in India. Additionally, key earnings reports from major firms like Alphabet and Tesla are anticipated, alongside ongoing geopolitical tensions involving Iran.